Publisher
Springer International Publishing
Reference128 articles.
1. Achrol AS, Pawlikowska L, McCulloch CE et al (2006) Tumor necrosis factor-alpha-238 G>A promoter polymorphism is associated with increased risk of new haemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37:231
2. Achrol AS, Kim H, Pawlikowska L et al (2007) Association of tumor necrosis factor-alpha-238>A and apolipopretein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery 61:731
3. Alkadhi H, Kollias SS, Crelier GR et al (2000) Plasticity of the human motor cortex in patient with arterio – venous malformations: a functional MR imaging study. AJNR Am J Neuroradiol 21:1423
4. Awad IA (1993) Dural arteriovenous malformations with aggressive clinical course. In: Awad IA, Barrow DL (eds) Dural arterovenous malformations. American Association of Neurological Surgeons, Park Ridge
5. Baharvahdat H, Blanc R, Termechi R et al (2014) Hemorrhagic complications after endovscujlar treatment of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 35:978